IP Library Granted Patent US 8,501,899
Granted Patent B2
US 8,501,899 · App. 13/356,552 · Granted Aug 6, 2013

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

Inventors: Kunsang Yoon (Madison, AL); J. Milton Harris (Huntsville, AL); Michael David Bentley (Huntsville, AL); Zhihao Fang (Madison, AL); Tacey Viegas (Madison, AL)
Assignee: Serina Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,501,899
App. No.
13/356,552
Granted
Aug 6, 2013
Kind
B2
Abstract

The present disclosure provides copolymers of 2-substituted-2-oxazolines possessing two or three reactive functional groups which are also chemically orthogonal. The copolymers described may be random copolymers, block copolymers or a mixture of random and block copolymer configurations. Furthermore, the present disclosure provides novel methods for synthesizing the above polymers and for conjugating to molecules such as targeting, diagnostic and therapeutic agents.

Claims (20)

1. A target molecule-POZ conjugate comprising at least one target molecule linked to a heterofunctional polyoxazoline derivative of the general structure:

{R 1 -{[N(COX)CH 2 CH 2 ] o —[N(COR 2 )CH 2 —CH 2 )] n —[N(COY)CH 2 —CH 2 )] m } a —K k —} d —R-Q q -Z

wherein:

R 1 is an initiating group;

R 2 is independently selected for each polyoxazoline chain from a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl, a substituted or unsubstituted aralkyl or a substituted or unsubstituted heterocyclylalkyl group;

X is a pendent moiety bearing a first functional group;

Y is a pendent moiety bearing a second functional group;

K is a linking moiety linking each polyoxazoline chain to a branching moiety R, K being independently selected for each polyoxazoline chain;

Q is a linking moiety linking the branching moiety R to Z;

R is a branching moiety capable of forming linkages with Z, either directly or through linking group Q, and with each polyoxazoline chain, either directly or through the linking group K;

Z is a moiety containing a third functional group or an inert group;

a independently selected for each polyoxazoline chain from ran which indicates a random copolymer or block which indicates a block copolymer;

d is an integer selected from 2-8;

k is an integer independently selected for each polyoxazoline chain from one or zero;

q is an integer selected from one or zero;

o is an integer independently selected for each polyoxazoline chain from 1-50;

m is an integer independently selected for each polyoxazoline chain from 0-50;

n is an integer selected from 0-1000;

wherein at least two of the first, second and third functional groups are chemically orthogonal to one another; and

wherein the at least one target molecule is linked to the polyoxazoline derivative through at least one of the first, second or third functional groups.

Assignments (1)
CHANGE OF NAME Recorded Apr 9, 2024
From: SERINA THERAPEUTICS, INC.
To: SERINA THERAPEUTICS (AL), INC.
Reel/Frame 067050/0622 →
Continuity (5)
Division 12787241 · May 25, 2010
Continuation In Part 12744472
Provisional Application 61020684 · Jan 11, 2008
Provisional Application 61029337 · Feb 16, 2008
Related Publication 20120123055A1 · May 17, 2012